BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
BioInvent International Net Income (Quarterly) : -13.12M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.12M |
| March 31, 2026 | -13.04M |
| December 31, 2025 | -13.37M |
| September 30, 2025 | -13.58M |
| June 30, 2025 | 4.014M |
| March 31, 2025 | -10.93M |
| December 31, 2024 | -10.84M |
| September 30, 2024 | -9.330M |
| June 30, 2024 | -12.84M |
| March 31, 2024 | -7.498M |
| December 31, 2023 | -9.108M |
| September 30, 2023 | -6.573M |
| June 30, 2023 | -8.381M |
| March 31, 2023 | -7.063M |
| December 31, 2022 | -7.304M |
| September 30, 2022 | -6.053M |
| June 30, 2022 | 17.00M |
| March 31, 2022 | -7.253M |
| December 31, 2021 | -8.887M |
| September 30, 2021 | -7.240M |
| June 30, 2021 | -6.810M |
| March 31, 2021 | -9.495M |
| December 31, 2020 | 3.312M |
| September 30, 2020 | -3.707M |
| June 30, 2020 | -4.064M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.372M |
| December 31, 2019 | -4.257M |
| September 30, 2019 | -3.871M |
| June 30, 2019 | -3.471M |
| March 31, 2019 | -3.026M |
| December 31, 2018 | -3.613M |
| September 30, 2018 | -2.499M |
| June 30, 2018 | -4.979M |
| March 31, 2018 | -3.07M |
| December 31, 2017 | -4.001M |
| September 30, 2017 | -2.633M |
| June 30, 2017 | -2.668M |
| March 31, 2017 | -2.504M |
| December 31, 2016 | -0.8045M |
| September 30, 2016 | -3.349M |
| June 30, 2016 | -3.297M |
| March 31, 2016 | 0.0387M |
| December 31, 2015 | -2.482M |
| September 30, 2015 | -2.665M |
| June 30, 2015 | -2.996M |
| March 31, 2015 | -2.608M |
| December 31, 2014 | -3.831M |
| September 30, 2014 | -1.482M |
| June 30, 2014 | 0.5625M |
| March 31, 2014 | -2.929M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 8.743M |
| Hansa Biopharma AB | -27.82M |
| BioArctic AB | -1.193M |
| Swedish Orphan Biovitrum AB | 117.25M |
| Diamyd Medical AB | -13.67M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.362M |
| Total Expenses (Quarterly) | 14.49M |
| EPS Diluted (Quarterly) | -0.1995 |
| Enterprise Value | 183.41M |
| Profit Margin (Quarterly) | -964.0% |
| Earnings Yield | -24.55% |
| Normalized Earnings Yield | -24.55 |